Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Volcano hopes to change its reputation with the $115 million acquisition of privately held AtheroMed and its Phoenix atherectomy catheter system.
The company, perhaps best known for its imaging technology, plans to broaden its horizons to include more therapeutic technologies, calling the AtheroMed buy an “important milestone” along the way. Read more
Stryker today denied rumors that it’s preparing a takeover bid for British orthopedics rival Smith & Nephew that sent SN shares to a record high today in London.
The rumors, sparked by acquisition speculation published in the Financial Times, prompted investors to boost share prices for Smith & Nephew to £1.12 apiece for a record high and a gain of some 17.5%, according to Reuters. Read more
FDA regulators today approved the 1st implantable heart monitor, CardioMEMS’ Champion HF technology for remote patient monitoring, spurring St. Jude Medical to exercise its option to acquire the company.
The Champion HF system is comprised of a battery-free implant that sits permanently in the pulmonary artery, a catheter-based delivery system and a home communicator that acquires and processes signals from the device and routes it to healthcare providers. Read more